Antibacterial Eliminates Recurrence of C. Difficile Infections in Phase II
MGB Biopharma has reported positive results from a phase II trial showing that its antibacterial…
20/05/2020 - 3 minutes
News and Trends
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
19/05/2020 - 5 minutes
Update: Spanish Food Startup Raises €12M to Grow Healthier Animal Fats
Update (18/05/2020): Cubiq Foods has received a €5M investment from food technology investor Blue Horizon…
18/05/2020 - 3 minutes
Affibody Signs €208M Deal To Market Autoimmune Drug in China
Swedish biotech Affibody and Chinese firm Inmagene Biopharmaceuticals will work together to develop and commercialize…
15/05/2020 - 3 minutes
Synthetic Biology Could Lead to Clean Energy Using Light and Carbon Dioxide
Researchers in Germany and France have combined synthetic biology with microfluidics to create artificial photosynthetic…
15/05/2020 - 3 minutes
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
15/05/2020 - 4 minutes
Oncopeptides’ Share Issue Bags €133M to Take Cancer Drug to Market
Swedish biotech Oncopeptides has raised €133M (SEK 1.4B) by issuing new company shares, surpassing expectations…
14/05/2020 - 3 minutes
EU Initiative Pumps up Funding for Covid-19 Research to €117M
The funding will go towards eight research projects that have been selected out of 144…
14/05/2020 - 3 minutes
Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon
Patients with the chronic liver disease NASH must now wait even longer for an approved…
13/05/2020 - 4 minutes
Gamida Cell’s Bone Marrow Transplant Cuts Treatment Time in Phase III
A rapid-acting bone marrow transplant developed by the Israeli biotech Gamida Cell was engrafted in…
12/05/2020 - 2 minutes
Italian Pharma Getting Back to Normal With Two Biotech Acquisitions
Despite the country being hard hit with Covid-19, Italian pharma seems to be getting back…
11/05/2020 - 4 minutes
Phase III Failure Sinks Drug for Rare Neurological Disorder
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
08/05/2020 - 4 minutes
